Latest News

Conference Coverage

Decoding biosimilar approvals

SAN FRANCISCO – Regulators must consider several factors when expanding the use of an approved biosimilar from one indication to another, based on...

Conference Coverage

PARP inhibitor prolongs PFS in mCRPC

BARCELONA – The PROfound trial shows that targeted therapy can be effective against metastatic castration-resistant prostate cancer bearing DNA...

Pages